Hormone Deficiency
16
1
1
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
12.5%
2 terminated out of 16 trials
81.8%
-4.7% vs benchmark
25%
4 trials in Phase 3/4
56%
5 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency
A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
High Fat vs High Protein and Appetite Hormones
Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency
Relationship Between Fertility Hormone Patterns and Pregnancy Rates.
Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause
Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy
Urethral Stricture After Transurethral Resection of the Prostate/Bladder: a Prospective Study of Risk Factors
Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)
Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population
Hormone Treatment in Growth Hormone and Testosterone Deficient Patients